创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

LI Zeqing, YUAN Songtao, XU Hanmei, HU Jialiang, XUE Jianpeng. Research Advances in Nanotechnology Drugs for the Treatment of Eye Diseases[J]. Progress in Pharmaceutical Sciences, 2020, 44(6): 459-465.
Citation: LI Zeqing, YUAN Songtao, XU Hanmei, HU Jialiang, XUE Jianpeng. Research Advances in Nanotechnology Drugs for the Treatment of Eye Diseases[J]. Progress in Pharmaceutical Sciences, 2020, 44(6): 459-465.

Research Advances in Nanotechnology Drugs for the Treatment of Eye Diseases

  • The complex drug delivery barrier leads to poor bioavailability and poor therapeutic effects of drugs for the treatment of problems with eyes. Studies have shown that nanocarrier-mediated drugs interact with the ocular mucosa, prolonging the retention time of the drug in the eye and increasing permeability. Novel drug carriers such as nanomicelles, nanoparticles, liposomes and nanoemulsions have the potential for ocular administration. This article reviews the recent research progress in ophthalmic drug delivery barriers, drug delivery routes and novel nanocarrier drugs, in order to provide reference for the development and clinical application of related drugs.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return